Is Leidos Holdings (LDOS) Undervalued After New Defense Contracts And Its AI Tool Launch?
Why recent contracts and AI tools matter for Leidos Holdings stock
Leidos Holdings (LDOS) has attracted fresh attention after securing two U.S. military contracts focused on cyber defense and behavioral health, alongside launching an AI-enabled geospatial intelligence tool aimed at faster, more accurate mapping.
Together, these developments highlight how Leidos Holdings is positioned across cybersecurity, defense health research, and AI driven software, areas that many investors track closely when assessing potential resilience and diversification in a government services stock.
Despite the new contracts and AI tools, Leidos Holdings' share price has been volatile, with the latest close at US$139.18 and the stock down 24.14% year to date on a share price basis. The 5-year total shareholder return of 51.94% points to longer term momentum that remains intact.
Compare Leidos Holdings with other AI driven defense and infrastructure plays and see which stocks made our hand picked 55 AI infrastructure stocks.
Given Leidos Holdings' 24% share price decline this year despite contract wins and steady reported revenue and net income growth, are investors reassessing the business fundamentals, or simply rotating away on sentiment as the valuation now suggests?
Most Popular Narrative: 11.1% Undervalued
The most followed narrative on Leidos Holdings values the stock at $156.60 per share, compared with the latest close at $139.18, and ties that gap directly to contract mix and future earnings power.
Leidos is positioned to benefit from increased, multi-year government funding focused on national security, defense modernization, border protection, and infrastructure, particularly through the One Big Beautiful Bill and related initiatives (e.g., FAA air traffic modernization, Golden Dome, maritime autonomy), which are expected to drive robust future revenue growth across core projects.
Accelerating customer demand for digital modernization, AI-powered solutions, and autonomous systems in defense, healthcare, and intelligence plays to Leidos' strengths and is leading to higher-quality, higher-margin contracts that improve net margins, as these capabilities command premium pricing and are in areas of secular growth.
Want to see what is sitting behind that fair value for Leidos Holdings. The narrative leans heavily on measured revenue growth, steady margins and a future earnings multiple that is not out of line with sector norms. Curious which specific top line path and profitability assumptions have to line up for that target to hold.
Result: Fair Value of $156.60 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Leidos Holdings still faces two clear swing factors: any shift in U.S. federal spending priorities, or tougher Health segment competition that pressures margins and future contract wins.
Find out about the key risks to this Leidos Holdings narrative.
Next Steps
If the mixed tone of this Leidos Holdings story leaves you undecided, it helps to see both sides quickly and then call it yourself using the 3 key rewards and 2 important warning signs
Looking for more investment ideas beyond Leidos Holdings?
Leidos Holdings gives useful context, but your portfolio may benefit from a broader watchlist of opportunities. Consider these focused stock ideas so you are not leaving potential on the table.
- Spot potential turnaround stories early by reviewing companies in the 22 elite penny stocks with strong financials that already show stronger financial footing than typical tiny stocks.
- Target quality at a sensible price by scanning the 50 high quality undervalued stocks that combine solid fundamentals with valuations some investors may be overlooking.
- Prioritize resilience by checking the 74 resilient stocks with low risk scores that pair sturdier balance sheets with calmer historical risk profiles.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com